Oxidative Stress Markers in Hypertrophic Cardiomyopathy

Bożena Szyguła-Jurkiewicz1, Wioletta Szczurek-Wasilewicz2, Tadeusz Osadnik2,3

  • 13rd Department of Cardiology, School of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.

Insights

Oxidative stress markers, including total oxidant status (TOS) and total antioxidant capacity (TAC), effectively predict hypertrophic cardiomyopathy (HCM). The oxidative stress index (OSI) demonstrated excellent predictive power for identifying HCM patients.

Area of Science:

  • Cardiology
  • Biochemistry
  • Oxidative Stress Research

Background:

  • Hypertrophic cardiomyopathy (HCM) is primarily linked to sarcomere dysfunction.
  • Secondary cardiac alterations, including those from oxidative stress, can also contribute to HCM.
  • Understanding oxidative-antioxidant balance is crucial for HCM research.

Purpose of the Study:

  • To investigate oxidative-antioxidant disturbances in patients with HCM.
  • To compare oxidative stress markers between HCM patients and healthy controls.
  • To evaluate the predictive power of oxidative stress markers for HCM detection.

Main Methods:

  • Enrolled 52 HCM patients and 97 controls, matched for age, BMI, and sex.
  • Measured total antioxidant capacity (TAC), total oxidant status (TOS), lipid hydroperoxide (LPH), and malondialdehyde (MDA) in peripheral blood.
  • Calculated the oxidative stress index (OSI) as the ratio of TOS to TAC.

Main Results:

  • TAC and TOS showed good predictive power for HCM detection (AUC 0.77 and 0.83).
  • The OSI demonstrated excellent predictive power for HCM detection (AUC 0.87).
  • Lipid peroxidation markers (LPH, MDA) also showed good predictive power (AUC 0.73 and 0.79).

Conclusions:

  • TOS, TAC, LPH, and MDA levels are valuable predictors for HCM detection.
  • The OSI provides a comprehensive assessment of oxidative stress with excellent predictive capability for identifying HCM.
  • Oxidative stress markers play a significant role in the pathophysiology and detection of HCM.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
80
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
388
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
250
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
52
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
80
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
54